WE ARE PHARMATHEN
Our leaders
John Nason
Group CEO
- 30 years of global biopharmaceutical leadership in operational roles at Teva, Bristol Myers Squibb, Novartis, and Sandoz.
- Strong track record ensuring the manufacturing and supply of critical medicines to patients while delivering large capital investments and supporting the people developments needed to secure future growth.
- MBA, B.Sc. in Chemistry and Microbiology.
- Currently holds the position of Group CEO
Ernesto Alegria
Group CFO
- Graduate degree in International Relations from Sciences-Po, Paris, France. B.A. in Economics and in Political Sciences from the University of California- Los Angeles (UCLA).
- 2024, joined Pharmathen as Group CFO and is based in the company’s offices in Switzerland.
- Has an extensive career in finance within the Pharmaceutical Industry in both publicly listed and private equity owned companies: Primex Pharmaceuticals, Acino, Takeda, Nycomed.
- Broad international background from Europe, the US, Latin America and other emerging markets.
Efthymios Koutris
Chief Development Officer
- Diploma in Chemical Engineering (M.Sc.Eng.) from Aristotle University of Thessaloniki
- 2000, started working at Pharmathen holding several roles in Research & Development
- Scientific achievements: 56 patent certificates & applications and development of more than 90 pharmaceutical products
- Project leader of the design and the investment plan of the 17000m2 production site at Sapes, Komotini
- Developed innovative drug delivery technologies/products with several applications (PF ophthalmics, sustained release, LAIs etc.)
Mohit Singh
Managing Director, BU Long Acting Technologies
- Engineer and MBA from the Indian Institute of Foreign Trade, New Delhi
- 2013, started working at Pharmathen in Business Development & Portfolio Management roles
- 16 years of experience, both in Developed and Emerging Markets, in Global Business Development, Strategy and Portfolio Management roles
- In the past, held leadership positions in various pharmaceutical companies such as Portfolio Lead for Branded Generics and Group Director of Business Development.
Gareth Williams
Managing Director, BU Global Generics
- Studied Finance, Accounting & Information Systems at University of Witwatersrand (Wits) in South Africa
- 2008, joined Pharmathen’s Business Development Department in the company’s UK offices
- Supported the growth of Pharmathen’s Global B2B presence in the last 10 years through various regional and managerial responsibilities within the Group’s Business Development Department
Dr. Evangelos Karavas
Scientific Advisor to Pharmathen SA BoD
- Chemist, PhD in Pharmaceutical Technology
- 1991, started working at Pharmathen holding several senior roles in Production, Quality and Research & Development
- Scientific achievements: 67, patent certificates & applications, more than 30 publications, 676 citations. Average citations per item 23,3.
- 2003, assumed the position of Vice President Research & Industrial Operations leading among others the expansion of Research & Development operations through two new R&D facilities of innovative formulations & APIs, as well as the creation of a state of the art manufacturing unit in Sapes, Northern Greece
Evgenios Papadopoulos
Senior Vice President Supply Chain
- M.Sc. in Management and Information Systems from London School of Economics
- 2014, joined Pharmathen as Operational Excellence Director
- With more than 15 years of leadership experience in performance improvement and transformation
- Held senior positions in global consulting firm for more than 10 years
- Supported the growth and transformation of Pharmathen in the last 7 years managing multiple value streams of the supply chain
Dr. Sotiria Chaitidou
Vice President R&D / Innovative Formulations
- PhD in Polymer Science and Technology (development of advanced polymeric materials for bio-separation and drug delivery applications)
- Diploma with distinction in Chemical Engineering ( M.Sc.Eng. ) from Aristotle University of Thessaloniki & Interdisciplinary Master (M.Sc.) in Nanosciences & Nanotechnologies
- 2009, started working at Pharmathen holding several roles in Research & Development
- Lead the development of Long-Acting Injectable products-LAIs (polymeric micro- and nano- particles, micro- and nano-suspensions, hydrogels)
- Contributed to the technology transfer of LAIs from small to industrial scale
Dr. Charalambos Constantinou
Vice President PMO
- PhD in Finance from the University of Cambridge
- M.Sc. in Finance and Economics from the University of Warwick
- 2022, started working at Pharmathen as Leader of the Project Management office
- Has significant experience in large transformation and reorganization programs
- Held several senior positions in large multinational organizations, including EY and Standard & Poor’s
George Drossos
Vice President People & Culture
- MBA from University of Hull & B.Sc. in Marketing Management from American College of Greece
- 2012, joined Pharmathen as Group HR Director
- With more than twenty years of leadership experience in driving multicultural organizations to high performance culture and achievements through centralization /digitalization of procedures and employer branding actions
- Developed and implemented a wide range of initiatives focused on the company’s global talent strategy, including staffing, career development and reward systems
- Improved leadership HR engagement, staff effectiveness and retention as well as developed and implemented HR processes infrastructure globally
- Under his leadership, the company was awarded as “Best Place to Work” for four consecutive years (2012-2016)
Efstathios Georgiou
Vice President Finance
Diego Koenig
Vice President M&A
- MBA from Nanyang Business School in Singapore
- M.A. in Strategy and International Management from the University of St. Gallen in Switzerland
- 2022, joined Pharmathen as Vice President M&A
- Held various global corporate M&A roles since 2009 in the life-science and chemical sectors, including the role of Head of M&A for Covestro
Pinelopi Menti
Vice President Customer & Supply Chain
- MBA (International Business) from University of East Anglia & B.Sc. in Biochemistry from University of Liverpool
- 2008, joined Pharmathen holding several positions in operations and commercial departments
- 20 years of experience in the pharmaceutical industry
- Since 2017, located at the company’s office in the Netherlands, leading the establishment and local operations of the office
Anand Misra
Vice President Strategic Sourcing
- MBA and Cost and Works Accountant degrees from leading Universities in India
- Engineer from the Indian Institute of Technology
- 2024, joined Pharmathen as Vice President Strategic Sourcing
- Over 23 years of professional experience across various verticals of Procurement and Supply Chain in multiple companies including GSK, J&J & Dabur and countries namely India and UK
Joanna Nidecka
Vice President, Industrial Operations – Sapes Site
• Over 25 years of international experience in building growth-oriented business strategies, leading international, interdisciplinary teams and managing transformation projects (industrial restructuration, optimization of manufacturing and packaging processes, improving site efficiency and customer satisfaction) across pharmaceutical & dietary supplements. Results-oriented & innovative.
• Executive MBA from Kozminski University
• M.Sc.Eng. in Chemical Engineering from Rzeszow University of Technology
• Postgraduate Studies IT Krakow University of Science and Technology
Konstantinos Papaioannou
Vice President Information Technology
- M.Sc. in Finance from Athens Laboratory of Business Administration & B.Sc. in Computer Science from University of Wollongong NSW Australia
- 2007, started working at Pharmathen in Corporate Information Technology Department
- ISO/IEC 27001 Certified – Foundation from the Professional Evaluation and Certification Board (PECB)
- Member of ISACA
- Held Information Technology and Cost Accounting Senior positions in large corporations including Fulgor SA, Club Hotel Casino Loutraki and Creta Farms
- Supported the growth and transformation of Pharmathen in the last 15 years, managing various fields of the Information Technology Department
Vicky Samara
Vice President R&D / Finished Dosage Forms - QP
- MBA from Kingston University London & Diploma in Chemistry from National and Kapodistrian University of Athens
- 2001, joined Pharmathen holding several senior roles in Research & Development
- Scientific achievements: 72 patent certificates and applications, development of more than 100 pharmaceutical products
- Qualified Person appointed by the National Organization for Medicines (EOF)
- Developed innovative drug delivery technologies/products (PF ophthalmics, sustained release, complex injectables etc.) and supported their approval globally
Argyro (Silvana) Tsitsirigou
Vice President Legal, Compliance & Intellectual Property
- LL.B. from Aristotle University of Thessaloniki, ΜΒΑ in Commercial and Economic Law from Aristotle University of Thessaloniki and M.Sc. in Business Studies for Law Practitioners from ALBA Graduate Business School
- 2011, joined Pharmathen, leading its Legal department
- Starting from 2017, assumes also leadership in Compliance Department and from 2019 in Intellectual Property Department
- More than 20 years of experience as in-house legal counsel in leading companies in various sectors
- Listed in the “GC Powerlist: Greece and Cyprus 2018” and achieved a team listing in “The Legal 500 GC Powerlist Greece & Cyprus: Teams 2019”
Anastasios Spyropoulos
Vice President Industrial Operations
- Diploma in Chemical Engineering (M.Sc.Eng.) from National Technical University of Athens (NTUA)
- B.Sc. in Chemical Engineering from Leeds University
- 2007, started working at Pharmathen holding several Senior positions in Manufacturing and Industrial Operations
- Over 20 years of experience in the Pharmaceutical industry